All filters
E-Posters
The Quantification Of HBeAg Levels Differ Among The Different Phases Of Hbv Infection, And Can Predict Therapeutic Outcome In The Setting Of Immunosuppression Driven Hbv Reactivation
L. Piermatteo
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Combined Use Of High-Sensitivity Serological And Virological Hbv Markers Can Make Better In Predicting The Occurrence Of HBV Reactivation And To Optimize Prophylaxis Duration In HBsAg-Negative/Anti-HBc-Positive Patients In The Context Of Oncohematological
M. Alkhatib
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
The Effectiveness Of The Application Of Serological Tests And Laboratory Indicators As Part Of Rita For The Detection Of Recent HIV Infection
A. Murzakova
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Ibalizumab Shows In Vitro Activity Against Group A And Group B HIV-2 Clinical Isolates
C. Charpentier
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
TDF Surveillance And Clinically Relevant Resistance In Spain: 2019 Update
F. García
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
HCV Resistance Associated Variants Following Directly Acting Agent Therapy Failure- Real Life Data From Poland
M. Parczewski
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Prevalence Of Transmitted Resistance Mutations To Rilpivirine And Doravirine In Treatment-Naive Patients In A Large Clinical And Resistance Database
F. Lombardi
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Absence Of GS-6207 Phenotypic Resistance In HIV Gag Cleavage Site Mutants, Patient Isolates With Gag Polymorphisms, And Isolates With Resistance To Existing Drug Classes
N. Margot
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Susceptibility To Bnabs Of Transmitted HIV Variants Among Recent Infections In France
K. Stefic
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Genotyping And Treatment Issues With Unusual 1E And 1G HCV Subtypes From African Subjects: Report Of Two Cases
C. Caudai
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Substantial Clustered Transmission Of The Acute Hepatitis C Among HIV Co-Infected Men-Who-Have-Sex-With-Men (MSM)
D. van de Vijver
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Antiretroviral Resistance In Patients With Multiple Treatment Failure In A Low-Middle Income Setting
J. L. Castillo
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Prevalence And Correlates Of Pre-Treatment HIV Drug Resistance Among HIV-Infected In The Republic Of Belarus
E. Gasich
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Late Presentation And HIV Drug Resistance In Patients Followed In Portugal Between 1984-2017
M. Pingarilho
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Prevalence Of Pretreatment HIV-1 Drug Resistance Among Treatment-Naïve Patients In The Russian Federation, 2014–2018
A. Kirichenko
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Genetic Characteristic Of HIV-1 In Patients With Treatment Failure In Kyrgyzstan In 2017-2018
D. Saleeva
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
The HBV Treatment Outcome To cART In HBV/HIV Co-Infected Patients Who Failed Lamivudine Containing Regimens
G. Dragovic Lukic
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Feasibility And Efficacy Assessment Of Hepatitis B Vaccination Among Adult Plwh And Vulnerable Population In Vinnytsia Region, Ukraine
T. Melnyk
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Hepatotoxicity And The Hepatic Panel Analysis Among HIV-Positive Ukrainian Patients Receiving Efaverentz And Dolutegravir-Containing Modes
A. Kiurdzhyieva
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Natural Course Of Hepatitis C Virus Infection: Which Factors Affect Spontaneous Clearance Of HCV Among The Ukrainian Population?
N. Zhandarova
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Effectiveness And Tolerability Of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/Taf) In HIV-1-Infected Adult Patients In German Routine Clinical Practice – 12-Month Results Of The BICSTaR Cohort
M. Heinzkill
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Long-Acting Cabotegravir + Rilpivirine For HIV Treatment: Flair Week 96 Results
J. Jeffrey
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Dual Therapy Including Dolutegravir Plus Boosted-Darunavir Ensures High Rate Of Virological Control And Rare Resistance Selection At Failure In Heavily Treatment Experienced PLWH
D. Armenia
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Real-World Effectiveness Of Elbasvir/Grazoprevir In The Treatment Of Patients With Hepatitis C Virus Genotype 1A Infection In Norway
R. A. Leiva
Presented at:
European Meeting on HIV & Hepatitis 2020